feed,title,long_url,short_url
SeekingAlpha,"Despite phase 2 COVID drug failure, Wainwright sees 82% upside for Theravance",https://seekingalpha.com/news/3708784,
SeekingAlpha,Which Cybersecurity Stocks Should You Buy?,https://seekingalpha.com/article/4436073,
SeekingAlpha,Barrick: Never Underestimate King Dollar,https://seekingalpha.com/article/4436062,
